Non-vesicular lipid transport by poxvirus A6 protein

痘病毒 A6 蛋白的非囊泡脂质转运

基本信息

  • 批准号:
    9379762
  • 负责人:
  • 金额:
    $ 23.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-05 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

Eukaryotic cells are organized with separate membrane-bound organelles with distinct lipid compositions. The lipid compositions are maintained through vesicular transport as well as the less-understood, lipid-transfer protein (LTP)-mediated, nonvesicular transport. It is important to gain a better understanding of lipid transfer process, as perturbations of lipid trafficking contribute to human pathologies including cancer, neurodegenerative disorders, cardiovascular diseases, obesity and diabetes. Viruses, as obligate intracellular parasites, have evolved strategies to manipulate the cellular membranes for entry, genome replication, virion production, and exit. Uncovering these strategies will not only reveal key viral replication steps for antivirals development but also provide mechanistic insights on fundamental cellular processes. Enveloped viruses typically acquire their outer lipid bilayer by budding from cellular membranes, a process that is similar to the formation of cellular transport vesicles. Poxviruses, however, are unusual in that their primary envelope is not acquired by budding but through extending of open-ended crescent membranes. The origin and biogenesis of the crescent membranes have puzzled virologists for over half a century, albeit recent studies suggest that the crescents may derive from the endoplasmic reticulum (ER) in a manner that is independent of vesicular transport from the ER. Five viral proteins, collectively termed viral membrane assembly proteins (VMAPs), have been found to be essential for the biogenesis of crescent membranes. The A6 protein of vaccinia virus is a key member of the VMAPs, which we discovered and have studied intensively. In recent studies, we achieved a breakthrough in structural analysis of the A6 protein by solving the crystal structures of both its N- and C- domains. Even more importantly, our structural and biochemical studies indicate that the C- domain is a novel lipid binding protein with an unusually high binding capacity for glycerol-phospholipids and that the N-domain regulates lipid binding. These led us to the innovative hypotheses that A6 is a lipid-transfer protein (LTP) and that poxviruses obtain their primary envelope by mimicking or hijacking the cellular LTP-mediated nonvesicular lipid transport process. We propose the following exploratory studies to test our novel hypotheses. Aim 1. To determine the specificity and stoichiometry of the lipids bound by A6 Aim 2. To determine the role of lipid binding of A6 in viral membrane biogenesis Aim 3. To determine the structural basis by which A6 N-domain regulates C-domain for lipid binding.
真核细胞由具有不同脂质成分的独立膜结合细胞器组成。脂质成分通过囊泡运输以及不太了解的脂质转移蛋白(LTP)介导的非囊泡运输来维持。更好地了解脂质转移过程非常重要,因为脂质运输的扰动会导致人类病理,包括癌症、神经退行性疾病、心血管疾病、肥胖和糖尿病。病毒作为专性细胞内寄生虫,已经进化出操纵细胞膜进入、基因组复制、病毒体产生和退出的策略。揭示这些策略不仅将揭示抗病毒药物开发的关键病毒复制步骤,还将提供对基本细胞过程的机制见解。有包膜病毒通常通过从细胞膜出芽来获得其外部脂质双层,这一过程类似于细胞运输囊泡的形成。然而,痘病毒的不同寻常之处在于,它们的初级包膜不是通过出芽获得的,而是通过开放式新月膜的延伸获得的。半个多世纪以来,新月膜的起源和生物发生一直困扰着病毒学家,尽管最近的研究表明,新月膜可能以一种独立于内质网囊泡运输的方式衍生自内质网(ER)。已发现五种病毒蛋白,统称为病毒膜组装蛋白(VMAP),对于新月膜的生物发生至关重要。痘苗病毒的A6蛋白是VMAPs的关键成员,我们发现并深入研究了它。在最近的研究中,我们通过解析 A6 蛋白 N 和 C 结构域的晶体结构,在结构分析方面取得了突破。更重要的是,我们的结构和生化研究表明,C 结构域是一种新型脂质结合蛋白,对甘油磷脂具有异常高的结合能力,而 N 结构域调节脂质结合。这些使我们提出了创新假设,即 A6 是一种脂质转移蛋白 (LTP),痘病毒通过模仿或劫持细胞 LTP 介导的非囊泡脂质转运过程来获得其初级包膜。我们提出以下探索性研究来检验我们的新假设。目标 1. 确定 A6 结合的脂质的特异性和化学计量学 目标 2. 确定 A6 的脂质结合在病毒膜生物合成中的作用 目标 3. 确定 A6 N 结构域调节 C 结构域脂质结合的结构基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Junpeng Deng其他文献

Junpeng Deng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Junpeng Deng', 18)}}的其他基金

Developing small molecule inhibitors for modulating cytokine IL18 activities
开发调节细胞因子 IL18 活性的小分子抑制剂
  • 批准号:
    10393624
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
Developing small molecule inhibitors for modulating cytokine IL18 activities
开发调节细胞因子 IL18 活性的小分子抑制剂
  • 批准号:
    10226420
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
  • 批准号:
    10463680
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Structure function studies of a molecular complex for generating viral membrane
用于生成病毒膜的分子复合物的结构功能研究
  • 批准号:
    10170273
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
  • 批准号:
    10382081
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
  • 批准号:
    10680408
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
  • 批准号:
    10675831
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
  • 批准号:
    10267770
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Structure function studies of a molecular complex for generating viral membrane
用于生成病毒膜的分子复合物的结构功能研究
  • 批准号:
    10057852
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Structure-function studies on a key signaling module from interleukin 17 receptor
白细胞介素17受体关键信号模块的结构-功能研究
  • 批准号:
    8771995
  • 财政年份:
    2014
  • 资助金额:
    $ 23.44万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 23.44万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 23.44万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 23.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了